These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 28867747)

  • 1. Involvement of Carrier-Mediated Transport at the Blood-Cerebrospinal Fluid Barrier in Spermine Clearance from Rat Brain.
    Akanuma SI; Shimada H; Kubo Y; Hosoya KI
    Biol Pharm Bull; 2017; 40(9):1599-1603. PubMed ID: 28867747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cationic drug-sensitive transport systems at the blood-cerebrospinal fluid barrier in para-tyramine elimination from rat brain.
    Akanuma SI; Yamazaki Y; Kubo Y; Hosoya KI
    Fluids Barriers CNS; 2018 Jan; 15(1):1. PubMed ID: 29307307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histamine elimination from the cerebrospinal fluid across the blood-cerebrospinal fluid barrier: involvement of plasma membrane monoamine transporter (PMAT/SLC29A4).
    Usui T; Nakazawa A; Okura T; Deguchi Y; Akanuma SI; Kubo Y; Hosoya KI
    J Neurochem; 2016 Nov; 139(3):408-418. PubMed ID: 27501284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The blood-cerebrospinal fluid barrier is a major pathway of cerebral creatinine clearance: involvement of transporter-mediated process.
    Tachikawa M; Kasai Y; Takahashi M; Fujinawa J; Kitaichi K; Terasaki T; Hosoya K
    J Neurochem; 2008 Oct; 107(2):432-42. PubMed ID: 18752646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the carrier-mediated process in the retina-to-blood transport of spermine at the inner blood-retinal barrier.
    Kubo Y; Tomise A; Tsuchiyama A; Akanuma S; Hosoya K
    Exp Eye Res; 2014 Jul; 124():17-23. PubMed ID: 24836980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clearance system for prostaglandin D2, a sleep-promoting factor, in cerebrospinal fluid: role of the blood-cerebrospinal barrier transporters.
    Tachikawa M; Tsuji K; Yokoyama R; Higuchi T; Ozeki G; Yashiki A; Akanuma S; Hayashi K; Nishiura A; Hosoya K
    J Pharmacol Exp Ther; 2012 Dec; 343(3):608-16. PubMed ID: 22931759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and possible role of creatine transporter in the brain and at the blood-cerebrospinal fluid barrier as a transporting protein of guanidinoacetate, an endogenous convulsant.
    Tachikawa M; Fujinawa J; Takahashi M; Kasai Y; Fukaya M; Sakai K; Yamazaki M; Tomi M; Watanabe M; Sakimura K; Terasaki T; Hosoya K
    J Neurochem; 2008 Nov; 107(3):768-78. PubMed ID: 18761709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transporter-mediated L-glutamate elimination from cerebrospinal fluid: possible involvement of excitatory amino acid transporters expressed in ependymal cells and choroid plexus epithelial cells.
    Akanuma S; Sakurai T; Tachikawa M; Kubo Y; Hosoya K
    Fluids Barriers CNS; 2015 Apr; 12():11. PubMed ID: 25925580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport systems of serine at the brain barriers and in brain parenchymal cells.
    Kasai Y; Tachikawa M; Hirose S; Akanuma S; Hosoya K
    J Neurochem; 2011 Jul; 118(2):304-13. PubMed ID: 21592122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Clearance from Cerebrospinal Fluid Mediated by Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8) at Arachnoid Membrane of Rats.
    Zhang Z; Tachikawa M; Uchida Y; Terasaki T
    Mol Pharm; 2018 Mar; 15(3):911-922. PubMed ID: 29436232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vivo and in-vitro evidence of a carrier-mediated efflux transport system for oestrone-3-sulphate across the blood-cerebrospinal fluid barrier.
    Kitazawa T; Hosoya K; Takahashi T; Sugiyama Y; Terasaki T
    J Pharm Pharmacol; 2000 Mar; 52(3):281-8. PubMed ID: 10757415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the blood-cerebrospinal fluid barrier transporter as a cerebral clearance system for prostaglandin E₂ produced in the brain.
    Tachikawa M; Ozeki G; Higuchi T; Akanuma S; Tsuji K; Hosoya K
    J Neurochem; 2012 Dec; 123(5):750-60. PubMed ID: 22978524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organic Anion-Transporting Polypeptide 1a4 (Oatp1a4/Slco1a4) at the Blood-Arachnoid Barrier is the Major Pathway of Sulforhodamine-101 Clearance from Cerebrospinal Fluid of Rats.
    Yaguchi Y; Tachikawa M; Zhang Z; Terasaki T
    Mol Pharm; 2019 May; 16(5):2021-2027. PubMed ID: 30977661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Smelling' the cerebrospinal fluid: olfactory signaling molecules are expressed in and mediate chemosensory signaling from the choroid plexus.
    Gonçalves I; Hubbard PC; Tomás J; Quintela T; Tavares G; Caria S; Barreiros D; Santos CR
    FEBS J; 2016 May; 283(9):1748-66. PubMed ID: 26934374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of quinolone antibiotics in rats: efflux from cerebrospinal fluid to the circulation.
    Ooie T; Suzuki H; Terasaki T; Sugiyama Y
    Pharm Res; 1996 Jul; 13(7):1065-8. PubMed ID: 8842046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible involvement of cationic-drug sensitive transport systems in the blood-to-brain influx and brain-to-blood efflux of amantadine across the blood-brain barrier.
    Suzuki T; Fukami T; Tomono K
    Biopharm Drug Dispos; 2015 Mar; 36(2):126-37. PubMed ID: 25410756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abundant Expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1, and xCT Transporters in Blood-Arachnoid Barrier of Pig and Polarized Localizations at CSF- and Blood-Facing Plasma Membranes.
    Uchida Y; Goto R; Takeuchi H; Łuczak M; Usui T; Tachikawa M; Terasaki T
    Drug Metab Dispos; 2020 Feb; 48(2):135-145. PubMed ID: 31771948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new in vitro model for blood-cerebrospinal fluid barrier transport studies: an immortalized choroid plexus epithelial cell line derived from the tsA58 SV40 large T-antigen gene transgenic rat.
    Hosoya K; Hori S; Ohtsuki S; Terasaki T
    Adv Drug Deliv Rev; 2004 Oct; 56(12):1875-85. PubMed ID: 15381338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrier-Mediated Process of Putrescine Elimination at the Rat Blood-Retinal Barrier.
    Tega Y; Kubo Y; Miura H; Ri K; Tomise A; Akanuma SI; Hosoya KI
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of ABC transporters as a detoxification system at the blood-CSF barrier.
    de Lange EC
    Adv Drug Deliv Rev; 2004 Oct; 56(12):1793-809. PubMed ID: 15381334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.